Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β/Smad pathway

British Journal of Dermatology

Volumn 166, Issue 3, 2012, Pages 564-574

  He, S ^a   Yang, Y ^a   Liu, X ^b   Huang, W ^a   Zhang, X ^a,c   Yang, S ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c HEFEI UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; ASTRAGALUS AND SALVIA MILTIORRHIZA EXTRACT; ASTRAGALUS MEMBRANACEUS EXTRACT; COLLAGEN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROLINE; SALVIA MILTIORRHIZA EXTRACT; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; KELOID; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; UPREGULATION; WESTERN BLOTTING;

ADULT; ANIMALS; CATTLE; CELL PROLIFERATION; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FEMALE; FIBROBLASTS; HUMANS; KELOID; MALE; MIDDLE AGED; PHOSPHORYLATION; SALVIA MILTIORRHIZA; SERUM; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 84857624552     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10674.x     Document Type: Article

References (41)

1. Alster TS, Tanzi EL,. Hypertrophic scars and keloids. Am J Clin Dermatol 2003; 4: 235-43.
2. Bran GM, Goessler UR, Hormann K, et al. Keloids: current concepts of pathogenesis (review). Int J Mol Med 2009; 24: 283-93.
3. Chike-Obi CJ, Cole PD, Brissett AE,. Keloids: pathogenesis, clinical features, and management. Semin Plast Surg 2009; 23: 178-84.
4. Juckett G, Hartman-Adams H,. Management of keloids and hypertrophic scars. Am Fam Physician 2009; 80: 253-60.
5. Lee TY, Chin GS, Kim WJ, et al. Expression of transforming growth factor beta 1, 2, 3 proteins in keloids. Ann Plast Surg 1999; 43: 179-84. (Pubitemid 29380019)
6. Bettinger DA, Yager DR, Diegelmann RF, et al. The effect of TGF-[beta] on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996; 98: 827-33. (Pubitemid 26322164)
7. Shi Y, Massagué J,. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113: 685-700. (Pubitemid 36724933)
8. Chin GS, Liu W, Peled Z, et al. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 2001; 108: 423-9. (Pubitemid 32706075)
9. Phan TT, Lim IJ, Aalami O, et al. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions. J Pathol 2005; 207: 232-42. (Pubitemid 41404154)
10. Gao Z, Wang Z, Shi Y, et al. Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA. Plast Reconstr Surg 2006; 118: 1328-37. (Pubitemid 44610382)
11. Wang Z, Gao Z, Shi Y, et al. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. J Plast Reconstr Aesthet Surg 2007; 60: 1193-9. (Pubitemid 47570828)
12. Yu H, Bock O, Bayat A, et al. Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring. J Plast Reconstr Aesthet Surg 2006; 59: 221-9.
13. Yang Y, Yang S, Chen M, et al. Compound Astragalus and Salvia miltiorrhiza extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts. J Ethnopharmacol 2008; 118: 264-70.
14. Liu X, Yang Y, Zhang X, et al. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell. J Gastroenterol Hepatol 2010; 25: 420-6.
15. Jagadeesan J, Bayat A,. Transforming growth factor beta (TGFbeta) and keloid disease. Int J Surg 2007; 5: 278-85. (Pubitemid 47095482)
16. Verrecchia F, Mauviel A,. Transforming growth factor-beta and fibrosis. World J Gastroenterol 2007; 13: 3056-62.
17. Yeh FL, Shen HD, Lin MW, et al. Keloid-derived fibroblasts have a diminished capacity to produce prostaglandin E2. Burns 2006; 32: 299-304.
18. Zhang Z, Li XJ, Liu Y, et al. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts. Burns 2007; 33: 634-41. (Pubitemid 46880036)
19. Zhou G, Kandala JC, Tyagi SC, et al. Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem 1996; 154: 171-8. (Pubitemid 26038059)
20. Mori S, Matsuzaki K, Yoshida K, et al. TGF-β and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene 2004; 23: 7416-29. (Pubitemid 39382144)
21. He S, Liu X, Yang Y, et al. Mechanisms of transforming growth factor beta/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts. Br J Dermatol 2010; 162: 538-46.
22. Tang B, Zhu B, Liang Y, et al. Asiaticoside suppresses collagen expression and TGF-beta/Smad signaling through inducing Smad7 and inhibiting TGF-betaRI and TGF-betaRII in keloid fibroblasts. Arch Dermatol Res 2011; 303: 563-72.
23. Hsu YC, Chen MJ, Yu YM, et al. Suppression of TGF-beta1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid. Arch Dermatol Res 2010; 302: 717-24.
24. Park G, Yoon BS, Moon JH, et al. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway. J Invest Dermatol 2008; 128: 2429-41.
25. Younai S, Nichter LS, Wellisz T, et al. Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 1994; 33: 148-51.
26. Fujiwara M, Muragaki Y, Ooshima A,. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol 2005; 153: 295-300. (Pubitemid 41228425)
27. Babu M, Diegelmann R, Oliver N,. Keloid fibroblasts exhibit an altered response to TGF-beta. J Invest Dermatol 1992; 99: 650-5.
28. Yoshimoto H, Ishihara H, Ohtsuru A, et al. Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol 1999; 154: 883-9. (Pubitemid 29122607)
29. Massagué J,. TGFβ in cancer. Cell 2008; 134: 215-30.
30. Matsuzaki K,. Modulation of TGF-beta signaling during progression of chronic liver diseases. Front Biosci 2009; 14: 2923-34.
31. Javelaud D, Mauviel A,. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 2005; 24: 5742-50. (Pubitemid 43086134)
32. Massagué J, Seoane J, Wotton D,. Smad transcription factors. Genes Dev 2005; 19: 2783-810. (Pubitemid 41739965)
33. Sekimoto G, Matsuzaki K, Yoshida K, et al. Reversible Smad-dependent signaling between tumor suppression and oncogenesis. Cancer Res 2007; 67: 5090-6. (Pubitemid 46997243)
34. Matsuzaki K, Okazaki K,. Transforming growth factor-β during carcinogenesis: the shift from epithelial to mesenchymal signaling. J Gastroenterol 2006; 41: 295-303. (Pubitemid 43834371)
35. Nakao A, Afrakhte M, Moren A, et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 1997; 389: 631-5. (Pubitemid 27446184)
36. Dooley S, Hamzavi J, Breitkopf K, et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003; 125: 178-91. (Pubitemid 36799118)
37. Kopp J, Preis E, Said H, et al. Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts. J Biol Chem 2005; 280: 21570-6. (Pubitemid 40805724)
38. Tuan TL, Wu H, Huang EY, et al. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol 2003; 162: 1579-89. (Pubitemid 36512841)
39. Tuan TL, Zhu JY, Sun B, et al. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 1996; 106: 1007-11. (Pubitemid 26153504)
40. Zhang Q, Wu Y, Ann DK, et al. Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 2003; 121: 1005-12. (Pubitemid 37430966)
41. Wu Y, Zhang Q, Ann DK, et al. Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol 2004; 286: C905-12. (Pubitemid 38543819)